Download by
Scanning QR Code
No Data
CN Stock MarketDetailed Quotes
301087 Cofoe Medical Technology
Watchlist
38.86
-0.22-0.56%
Market Closed 09/28 15:00 CST
39.25High38.83Low8.70KlotVolume
39.08Open39.08Pre Close33.88MTurnover0.98%Turnover Ratio21.88P/E (TTM)8.10BMarket Cap52.5552wk High26.86P/E (Static)208.49MShares28.7752wk Low1.67P/B3.43BFloat Cap70.65Historical High46.90Limit Up88.36MShs Float28.77Historical Low31.26Limit Down1.08%Amplitude4.24KlotAsk1.20Dividend TTM38.96Avg Price4.36KlotBid3.09%Div YieldTTM100Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Cofoe Medical Technology Company
The company was founded in 2005, has 26 subsidiaries and nearly 100 branches, and has now developed into a group enterprise integrating medical device R&D, manufacturing, sales and service. The company is a leading large-scale, comprehensive household medical device enterprise in China, specializing in R&D, production, sales and service of household medical devices. Company products: Household medical devices mainly refer to medical devices suitable for public use outside hospitals for the purpose of testing, treatment, health care and rehabilitation, which are safe and reliable, easy to operate, small in size, and easy to carry. There are many types of household medical equipment products. The company's main products cover five major fields: health monitoring, rehabilitation aids, respiratory support, traditional Chinese medicine physiotherapy, and medical care.
News
Kefu Healthcare (301087): Product Upgrades, Self-Production+Hearing Expansion, and Store Card Slots Drive the Company's Healthy Growth
A leading household medical device company, is in a period of rapid growth. It has been covered for the first time. It has been covered for the first time. Granted a “buy” rating, Kefu Medical has focused on household medical devices for 14 years. After years of deepening channel cultivation and R&D and product expansion, it has formed health monitoring, rehabilitation aids, and respiratory support
Kefu Healthcare (301087): Performance growth is resilient enough to be optimistic about steady growth throughout the year
Event Overview On August 29, 2023, the company released its 2023 interim report. In the first half of 2023, it achieved revenue of 1,519 billion yuan, an increase of 17.23% over the previous year; it achieved net profit of 199 million yuan, a year-on-year increase of 52 million yuan.
Kefu Healthcare (301087.SZ): By the end of August, nearly 700 hearing testing centers had been signed and nearly 600 had been opened
Glonghui September 4 丨 Kefu Healthcare (301087.SZ) recently received a survey of specific subjects on “Long-term plans and future positioning of the Jianer store?” The company replied that by the end of August, nearly 700 hearing testing and matching centers had been signed and nearly 600 had been opened. It will continue to expand at a high rate in the next 1-2 years, and strive to become the leading hearing service chain brand in China. Currently, the concentration of the hearing industry is low. Through continuous improvement of coverage and professional service capabilities, Jianear Hearing hopes to better serve consumers. At the same time, through the development of hearing testing equipment and products, the company's competitiveness will be enhanced and the cost of opening a store will be reduced.